0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Candidiasis Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-27G9867
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Candidiasis Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Candidiasis Drug Market Research Report 2025

Code: QYRE-Auto-27G9867
Report
July 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Candidiasis Drug Market Size

The global market for Candidiasis Drug was valued at US$ 1274 million in the year 2024 and is projected to reach a revised size of US$ 1760 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Candidiasis Drug Market

Candidiasis Drug Market

The standard recommended dose for most Candida infections is fluconazole at 800 mg as the loading dose, followed by fluconazole at a dose of 400 mg/d either intravenously or orally for at least 2 weeks of therapy after a demonstrated negative blood culture result or clinical signs of improvement.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Candidiasis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candidiasis Drug.
The Candidiasis Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Candidiasis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Candidiasis Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Candidiasis Drug Market Report

Report Metric Details
Report Name Candidiasis Drug Market
Accounted market size in year US$ 1274 million
Forecasted market size in 2031 US$ 1760 million
CAGR 4.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Oral
  • External Use
  • Other
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, Perrigo, J & J, Pfizer, Bristol-Myers Squibb, Effik, Teva, Sanofi, Cisen Pharmaceutical, Kingyork Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Candidiasis Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Candidiasis Drug Market growing?

Ans: The Candidiasis Drug Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Candidiasis Drug Market size in 2031?

Ans: The Candidiasis Drug Market size in 2031 will be US$ 1760 million.

Who are the main players in the Candidiasis Drug Market report?

Ans: The main players in the Candidiasis Drug Market are Bayer, Perrigo, J & J, Pfizer, Bristol-Myers Squibb, Effik, Teva, Sanofi, Cisen Pharmaceutical, Kingyork Group

What are the Application segmentation covered in the Candidiasis Drug Market report?

Ans: The Applications covered in the Candidiasis Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Candidiasis Drug Market report?

Ans: The Types covered in the Candidiasis Drug Market report are Oral, External Use, Other

Recommended Reports

Anti-infective Drugs

Fungal & Yeast Infections

Other Therapeutic Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Candidiasis Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 External Use
1.2.4 Other
1.3 Market by Application
1.3.1 Global Candidiasis Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Candidiasis Drug Market Perspective (2020-2031)
2.2 Global Candidiasis Drug Growth Trends by Region
2.2.1 Global Candidiasis Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Candidiasis Drug Historic Market Size by Region (2020-2025)
2.2.3 Candidiasis Drug Forecasted Market Size by Region (2026-2031)
2.3 Candidiasis Drug Market Dynamics
2.3.1 Candidiasis Drug Industry Trends
2.3.2 Candidiasis Drug Market Drivers
2.3.3 Candidiasis Drug Market Challenges
2.3.4 Candidiasis Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Candidiasis Drug Players by Revenue
3.1.1 Global Top Candidiasis Drug Players by Revenue (2020-2025)
3.1.2 Global Candidiasis Drug Revenue Market Share by Players (2020-2025)
3.2 Global Candidiasis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Candidiasis Drug Revenue
3.4 Global Candidiasis Drug Market Concentration Ratio
3.4.1 Global Candidiasis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Candidiasis Drug Revenue in 2024
3.5 Global Key Players of Candidiasis Drug Head office and Area Served
3.6 Global Key Players of Candidiasis Drug, Product and Application
3.7 Global Key Players of Candidiasis Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Candidiasis Drug Breakdown Data by Type
4.1 Global Candidiasis Drug Historic Market Size by Type (2020-2025)
4.2 Global Candidiasis Drug Forecasted Market Size by Type (2026-2031)
5 Candidiasis Drug Breakdown Data by Application
5.1 Global Candidiasis Drug Historic Market Size by Application (2020-2025)
5.2 Global Candidiasis Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Candidiasis Drug Market Size (2020-2031)
6.2 North America Candidiasis Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Candidiasis Drug Market Size by Country (2020-2025)
6.4 North America Candidiasis Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Candidiasis Drug Market Size (2020-2031)
7.2 Europe Candidiasis Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Candidiasis Drug Market Size by Country (2020-2025)
7.4 Europe Candidiasis Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Candidiasis Drug Market Size (2020-2031)
8.2 Asia-Pacific Candidiasis Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Candidiasis Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Candidiasis Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Candidiasis Drug Market Size (2020-2031)
9.2 Latin America Candidiasis Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Candidiasis Drug Market Size by Country (2020-2025)
9.4 Latin America Candidiasis Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Candidiasis Drug Market Size (2020-2031)
10.2 Middle East & Africa Candidiasis Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Candidiasis Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Candidiasis Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Candidiasis Drug Introduction
11.1.4 Bayer Revenue in Candidiasis Drug Business (2020-2025)
11.1.5 Bayer Recent Development
11.2 Perrigo
11.2.1 Perrigo Company Details
11.2.2 Perrigo Business Overview
11.2.3 Perrigo Candidiasis Drug Introduction
11.2.4 Perrigo Revenue in Candidiasis Drug Business (2020-2025)
11.2.5 Perrigo Recent Development
11.3 J & J
11.3.1 J & J Company Details
11.3.2 J & J Business Overview
11.3.3 J & J Candidiasis Drug Introduction
11.3.4 J & J Revenue in Candidiasis Drug Business (2020-2025)
11.3.5 J & J Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Candidiasis Drug Introduction
11.4.4 Pfizer Revenue in Candidiasis Drug Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Candidiasis Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Candidiasis Drug Business (2020-2025)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Effik
11.6.1 Effik Company Details
11.6.2 Effik Business Overview
11.6.3 Effik Candidiasis Drug Introduction
11.6.4 Effik Revenue in Candidiasis Drug Business (2020-2025)
11.6.5 Effik Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Candidiasis Drug Introduction
11.7.4 Teva Revenue in Candidiasis Drug Business (2020-2025)
11.7.5 Teva Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Candidiasis Drug Introduction
11.8.4 Sanofi Revenue in Candidiasis Drug Business (2020-2025)
11.8.5 Sanofi Recent Development
11.9 Cisen Pharmaceutical
11.9.1 Cisen Pharmaceutical Company Details
11.9.2 Cisen Pharmaceutical Business Overview
11.9.3 Cisen Pharmaceutical Candidiasis Drug Introduction
11.9.4 Cisen Pharmaceutical Revenue in Candidiasis Drug Business (2020-2025)
11.9.5 Cisen Pharmaceutical Recent Development
11.10 Kingyork Group
11.10.1 Kingyork Group Company Details
11.10.2 Kingyork Group Business Overview
11.10.3 Kingyork Group Candidiasis Drug Introduction
11.10.4 Kingyork Group Revenue in Candidiasis Drug Business (2020-2025)
11.10.5 Kingyork Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Candidiasis Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral
 Table 3. Key Players of External Use
 Table 4. Key Players of Other
 Table 5. Global Candidiasis Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Candidiasis Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Candidiasis Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Candidiasis Drug Market Share by Region (2020-2025)
 Table 9. Global Candidiasis Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Candidiasis Drug Market Share by Region (2026-2031)
 Table 11. Candidiasis Drug Market Trends
 Table 12. Candidiasis Drug Market Drivers
 Table 13. Candidiasis Drug Market Challenges
 Table 14. Candidiasis Drug Market Restraints
 Table 15. Global Candidiasis Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Candidiasis Drug Market Share by Players (2020-2025)
 Table 17. Global Top Candidiasis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Drug as of 2024)
 Table 18. Ranking of Global Top Candidiasis Drug Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Candidiasis Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Candidiasis Drug, Headquarters and Area Served
 Table 21. Global Key Players of Candidiasis Drug, Product and Application
 Table 22. Global Key Players of Candidiasis Drug, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Candidiasis Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Candidiasis Drug Revenue Market Share by Type (2020-2025)
 Table 26. Global Candidiasis Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Candidiasis Drug Revenue Market Share by Type (2026-2031)
 Table 28. Global Candidiasis Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Candidiasis Drug Revenue Market Share by Application (2020-2025)
 Table 30. Global Candidiasis Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Candidiasis Drug Revenue Market Share by Application (2026-2031)
 Table 32. North America Candidiasis Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Candidiasis Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Candidiasis Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Candidiasis Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Candidiasis Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Candidiasis Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Candidiasis Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Candidiasis Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Candidiasis Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Candidiasis Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Candidiasis Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Candidiasis Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Candidiasis Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Candidiasis Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Candidiasis Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Bayer Company Details
 Table 48. Bayer Business Overview
 Table 49. Bayer Candidiasis Drug Product
 Table 50. Bayer Revenue in Candidiasis Drug Business (2020-2025) & (US$ Million)
 Table 51. Bayer Recent Development
 Table 52. Perrigo Company Details
 Table 53. Perrigo Business Overview
 Table 54. Perrigo Candidiasis Drug Product
 Table 55. Perrigo Revenue in Candidiasis Drug Business (2020-2025) & (US$ Million)
 Table 56. Perrigo Recent Development
 Table 57. J & J Company Details
 Table 58. J & J Business Overview
 Table 59. J & J Candidiasis Drug Product
 Table 60. J & J Revenue in Candidiasis Drug Business (2020-2025) & (US$ Million)
 Table 61. J & J Recent Development
 Table 62. Pfizer Company Details
 Table 63. Pfizer Business Overview
 Table 64. Pfizer Candidiasis Drug Product
 Table 65. Pfizer Revenue in Candidiasis Drug Business (2020-2025) & (US$ Million)
 Table 66. Pfizer Recent Development
 Table 67. Bristol-Myers Squibb Company Details
 Table 68. Bristol-Myers Squibb Business Overview
 Table 69. Bristol-Myers Squibb Candidiasis Drug Product
 Table 70. Bristol-Myers Squibb Revenue in Candidiasis Drug Business (2020-2025) & (US$ Million)
 Table 71. Bristol-Myers Squibb Recent Development
 Table 72. Effik Company Details
 Table 73. Effik Business Overview
 Table 74. Effik Candidiasis Drug Product
 Table 75. Effik Revenue in Candidiasis Drug Business (2020-2025) & (US$ Million)
 Table 76. Effik Recent Development
 Table 77. Teva Company Details
 Table 78. Teva Business Overview
 Table 79. Teva Candidiasis Drug Product
 Table 80. Teva Revenue in Candidiasis Drug Business (2020-2025) & (US$ Million)
 Table 81. Teva Recent Development
 Table 82. Sanofi Company Details
 Table 83. Sanofi Business Overview
 Table 84. Sanofi Candidiasis Drug Product
 Table 85. Sanofi Revenue in Candidiasis Drug Business (2020-2025) & (US$ Million)
 Table 86. Sanofi Recent Development
 Table 87. Cisen Pharmaceutical Company Details
 Table 88. Cisen Pharmaceutical Business Overview
 Table 89. Cisen Pharmaceutical Candidiasis Drug Product
 Table 90. Cisen Pharmaceutical Revenue in Candidiasis Drug Business (2020-2025) & (US$ Million)
 Table 91. Cisen Pharmaceutical Recent Development
 Table 92. Kingyork Group Company Details
 Table 93. Kingyork Group Business Overview
 Table 94. Kingyork Group Candidiasis Drug Product
 Table 95. Kingyork Group Revenue in Candidiasis Drug Business (2020-2025) & (US$ Million)
 Table 96. Kingyork Group Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. Candidiasis Drug Picture
 Figure 2. Global Candidiasis Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Candidiasis Drug Market Share by Type: 2024 VS 2031
 Figure 4. Oral Features
 Figure 5. External Use Features
 Figure 6. Other Features
 Figure 7. Global Candidiasis Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Candidiasis Drug Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Retail Pharmacy Case Studies
 Figure 11. Other Case Studies
 Figure 12. Candidiasis Drug Report Years Considered
 Figure 13. Global Candidiasis Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Candidiasis Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Candidiasis Drug Market Share by Region: 2024 VS 2031
 Figure 16. Global Candidiasis Drug Market Share by Players in 2024
 Figure 17. Global Top Candidiasis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Drug as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Candidiasis Drug Revenue in 2024
 Figure 19. North America Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Candidiasis Drug Market Share by Country (2020-2031)
 Figure 21. United States Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Candidiasis Drug Market Share by Country (2020-2031)
 Figure 25. Germany Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Candidiasis Drug Market Share by Region (2020-2031)
 Figure 33. China Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Candidiasis Drug Market Share by Country (2020-2031)
 Figure 41. Mexico Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Candidiasis Drug Market Share by Country (2020-2031)
 Figure 45. Turkey Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Candidiasis Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Bayer Revenue Growth Rate in Candidiasis Drug Business (2020-2025)
 Figure 49. Perrigo Revenue Growth Rate in Candidiasis Drug Business (2020-2025)
 Figure 50. J & J Revenue Growth Rate in Candidiasis Drug Business (2020-2025)
 Figure 51. Pfizer Revenue Growth Rate in Candidiasis Drug Business (2020-2025)
 Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Candidiasis Drug Business (2020-2025)
 Figure 53. Effik Revenue Growth Rate in Candidiasis Drug Business (2020-2025)
 Figure 54. Teva Revenue Growth Rate in Candidiasis Drug Business (2020-2025)
 Figure 55. Sanofi Revenue Growth Rate in Candidiasis Drug Business (2020-2025)
 Figure 56. Cisen Pharmaceutical Revenue Growth Rate in Candidiasis Drug Business (2020-2025)
 Figure 57. Kingyork Group Revenue Growth Rate in Candidiasis Drug Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart